- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Ionising Radiation (Medical Exposure) Regulations 2017.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 4
1.—(1) A person required by regulation 5 to hold a licence must make an application to the Licensing Authority in the form specified from time to time by the Licensing Authority.
(2) A person applying for a licence under sub-paragraph (1) must provide to the Licensing Authority—
(a)such of the information described in paragraph 2 as the Licensing Authority may from time to time specify necessary to determine the licence application;
(b)upon request in writing, any other information which the Licensing Authority requires for the purpose of considering the licence application; and
(c)the fee specified in paragraph 4.
(3) A person issued a licence under these Regulations (“the licensee”) must apply to the Licensing Authority if the licensee seeks a material change to the licence in respect of any matter dealt with by that licence.
Commencement Information
I1Sch. 1 para. 1 in force at 6.2.2018, see reg. 1
2. The information referred to in paragraph 1(2) is information relating to—
(a)responsibilities and organisational arrangements for protection and safety;
(b)staff competences, including information and training;
(c)design features of the radiological installation and of radiation sources;
(d)anticipated occupational and public exposures in normal operation;
(e)safety assessment of the activities and the facility in order to—
(i)identify ways in which potential exposures or accidental and unintended medical exposures could occur;
(ii)estimate, to the extent practicable, the probabilities and magnitude of potential exposures;
(iii)assess the quality and extent of protection and safety provisions, including engineering features, as well as administrative procedures;
(iv)define the operational limits and conditions of operation;
(f)emergency procedures;
(g)maintenance, testing, inspection and servicing so as to ensure that the radiation source and the facility continue to meet the design requirements, operational limits and conditions of operation throughout their lifetime;
(h)management of radioactive waste and arrangements for the disposal of such waste, in accordance with applicable regulatory requirements;
(i)management of disused sources;
(j)quality assurance.
Commencement Information
I2Sch. 1 para. 2 in force at 6.2.2018, see reg. 1
3. The licensing authority may, on a case by case basis, relax any of the requirements relating to the making of an application for a licence in respect of a proposed urgent medical radiological exposure.
Commencement Information
I3Sch. 1 para. 3 in force at 6.2.2018, see reg. 1
4.—(1) The fee payable by a person described in column 1 of Table 1 in respect of an application type specified in column 2 of that table is the corresponding amount in column 3.
(2) No fee is payable where the amount specified in column 2 is “0”.
Licence type (1) | Application type (2) | Fee (£) (3) |
---|---|---|
Employer | New | 250 |
Amendment of an existing licence | 200 | |
Renewal of an existing licence | 200 | |
Notification | 0 | |
Practitioner | New | 0 |
Amendment of an existing licence | 0 | |
Renewal of an existing licence | 0 | |
Particular patient request | 0 |
Commencement Information
I4Sch. 1 para. 4 in force at 6.2.2018, see reg. 1
5.—(1) A person who is aggrieved (“an aggrieved person”) by—
(a)a decision of the Licensing Authority—
(i)refusing to issue a licence;
(ii)imposing a limit of time upon a licence; or
(iii)revoking a licence; or
(b)the terms of any conditions attached to a licence by the Licensing Authority,
may ask the Licensing Authority for a review.
(2) Any aggrieved person seeking a review must—
(a)within 28 days of the date that the person was notified of the decision, or the terms, which caused them to become an aggrieved person request the Licensing Authority to undertake a review described in paragraph (1) ; and
(b)must particularise in writing the reasons for seeking the review.
(3) The Licensing Authority must undertake a review, and provide the results of that review in writing to the aggrieved person.
Commencement Information
I5Sch. 1 para. 5 in force at 6.2.2018, see reg. 1
6. A fee payable under these Regulations is payable to the Secretary of State.
Commencement Information
I6Sch. 1 para. 6 in force at 6.2.2018, see reg. 1
Regulation 6
1. The employer’s written procedures for exposures must include procedures—E+W+S
(a)to identify correctly the individual to be exposed to ionising radiation;
(b)to identify individuals entitled to act as referrer or practitioner or operator within a specified scope of practice;
(c)for making enquiries of individuals of childbearing potential to establish whether the individual is or may be pregnant or breastfeeding;
(d)to ensure that quality assurance programmes in respect of written procedures, written protocols, and equipment are followed;
(e)for the assessment of patient dose and administered activity;
(f)for the use and review of such diagnostic reference levels as the employer may have established for radiodiagnostic examinations falling within regulation 3(a), (b), (e) and (f);
(g)for determining whether the practitioner or operator is required to effect one or more of the matters set out in regulation 12(4) including criteria on how to effect those matters and in particular procedures for the use of dose constraints established by the employer for biomedical and medical research programmes falling within regulation 3(c) where no direct medical benefit for the individual is expected from the exposure;
(h)for the giving of information and written instructions as referred to in regulation 12(6);
(i)providing that wherever practicable, and prior to an exposure taking place, the individual to be exposed or their representative is provided with adequate information relating to the benefits and risks associated with the radiation dose from the exposure;
(j)for the carrying out and recording of an evaluation for each exposure including, where appropriate, factors relevant to patient dose;
(k)to ensure that the probability and magnitude of accidental or unintended exposure to individuals from radiological practices are reduced so far as reasonably practicable;
(l)to ensure that the referrer, the practitioner, and the individual exposed or their representative are informed of the occurrence of any relevant clinically significant unintended or accidental exposure, and of the outcome of the analysis of this exposure;
(m)to be observed in the case of non-medical imaging exposures;
(n)to establish appropriate dose constraints and guidance for the exposure of carers and comforters.
Commencement Information
I7Sch. 2 para. 1 in force at 6.2.2018, see reg. 1
Regulation 17
1. Practitioners and operators must have successfully completed training, including theoretical knowledge and practical experience, in—E+W+S
(a)such of the subjects detailed in Table 1 as are relevant to their functions as practitioner or operator; and
(b)such of the subjects detailed in Table 2 as are relevant to their specific area of practice.
Fundamental Physics of Radiation | |
---|---|
Properties of Radiation | Excitation and ionisation |
Attenuation of ionising radiation | |
Scattering and absorption | |
Radiation Hazards and Dosimetry | Biological effects of radiation – stochastic and deterministic |
Risks and benefits of radiation | |
Absorbed dose, equivalent dose, effective dose, other dose indicators and their units | |
Management and Radiation Protection of the individual being exposed | |
Special Attention Areas | Pregnancy and potential pregnancy |
Asymptomatic individuals | |
Breastfeeding | |
Infants and children | |
Medical and biomedical research | |
Health screening | |
Non-medical imaging | |
Carers and comforters | |
High dose techniques | |
Justification | Justification of the individual exposure |
Use of existing appropriate radiological information | |
Alternative techniques | |
Radiation Protection | Diagnostic reference levels |
Dose Constraints | |
Dose Optimisation | |
Dose reduction devices and techniques | |
Dose recording and dose audit | |
General radiation protection | |
Quality Assurance and Quality Control including routine inspection and testing of equipment | |
Risk communication | |
Use of radiation protection devices | |
Statutory Requirements and Non-Statutory Regulations | |
Regulations | |
Non-statutory guidance | |
Local procedures and protocols | |
Individual responsibilities relating to exposures | |
Responsibility for radiation safety | |
Clinical audit |
All Modalities | |
---|---|
General | Fundamentals of radiological anatomy |
Factors affecting radiation dose | |
Dosimetry | |
Fundamentals of clinical evaluation | |
Identification of the individual being exposed | |
Diagnostic radiology | |
General | Principles of radiological techniques |
Production of X-rays | |
Equipment selection and use | |
Specialised Techniques | Computed Tomography: advanced applications |
Interventional procedures | |
Cone Beam Computed Tomography | |
Hybrid imaging | |
Fundamentals of Image Acquisition etc. | Optimisation of image quality and radiation dose |
Image formats, acquisition, processing, display and storage | |
Contrast Media | Use and preparation |
Contraindications | |
Use of contrast injection systems | |
Radiotherapy | |
General | Production of ionising radiation |
Treatment of malignant disease | |
Treatment of benign disease | |
Principles of external beam radiotherapy | |
Principles of brachytherapy | |
Specialised techniques | Intra-operative radiotherapy Stereotactic radiotherapy and radiosurgery Stereotactic ablative radiotherapy Proton therapy MR Linac therapy |
Radiobiological Aspects for Radiotherapy | Fractionation Dose rate |
Radiosensitisation | |
Target volumes | |
Practical Aspects for Radiotherapy | Localisation equipment selection Therapy equipment selection Verification techniques including on-treatment imaging |
Treatment planning systems | |
Radiation Protection Specific to Radiotherapy | Side effects—early and late Toxicity |
Assessment of efficacy | |
Nuclear Medicine | |
General | Atomic structure and radioactivity |
Radioactive decay | |
Principles of molecular imaging and non-imaging exposures | |
Principles of molecular radiotherapy | |
Molecular Radiotherapy | Dose rate Fractionation Radiobiology aspects Radiosensitisation |
Specialised techniques | Quantitative imaging – advanced applications Hybrid imaging – advanced applications Selective Internal Radiation Therapy |
Principles of Radiation Detection, Instrumentation and Equipment | Types of detection systems Optimisation of image quality and radiation dose Image acquisition, artefacts, processing, display and storage |
Radiopharmaceuticals | Calibration |
Working practices in the radiopharmacy | |
Preparation of individual doses | |
Radiation Protection Specific to Nuclear Medicine | Conception, pregnancy and breastfeeding Arrangements for radioactive individuals |
Commencement Information
I8Sch. 3 para. 1 in force at 6.2.2018, see reg. 1
Regulation 21
1.—(1) The Justification of Practices Involving Ionising Radiation Regulations 2004(1) are amended as follows.
[F1(2) For regulation 21 (saving for medical practices) substitute—
“21. Nothing in regulation 4(5) or 5(3) shall prevent anything permitted under regulation 11 of the Ionising Radiation (Medical Exposure) Regulations 2017 or regulation 11 of the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018.”.]
Textual Amendments
F1Sch. 4 para. 1(2) substituted (6.2.2018) by The Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018 (S.I. 2018/121), regs. 1(2), 2(4)(a)
Commencement Information
I9Sch. 4 para. 1 in force at 6.2.2018, see reg. 1
2.—(1) The Human Medicines Regulations 2012(2) are amended as follows.
[F2(2) In regulation 173 (exemption for certain radiopharmaceuticals), for paragraph (d) substitute—
“(d)for administration—
(i)in England and Wales and Scotland in accordance with a licence issued under the Ionising Radiation (Medical Exposure) Regulations 2017;
(ii)in Northern Ireland in accordance with a licence issued under the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018.”.”;]
[F3(3) For regulation 240 (radioactive medicinal products), substitute—
240.—(1) Regulation 214(2) does not apply to—
(a)a radioactive substance, administration of which results in a medical exposure; or
(b)any other prescription only medicine if it is being administered in connection with a medical exposure,
if Conditions A to E are met.
(2) Condition A is that the prescription only medicine is administered by an operator acting in accordance with the procedures and protocols referred to—
(a)in England and Wales and Scotland, in regulation 6(1) and (4) of the Ionising Radiation (Medical Exposure) Regulations 2017 which apply to the exposure;
(b)in Northern Ireland, in regulation 6(1) and (4) of the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018 which apply to the exposure.
(3) Condition B is that the medical exposure has been authorised by—
(a)an IRME practitioner; or
(b)where it is not practical for an IRME practitioner to authorise the exposure, an operator acting in accordance with written guidelines issued by an IRME practitioner.
(4) Condition C is that—
(a)in England and Wales and Scotland, the IRME practitioner mentioned in sub-paragraph (a) or (b) of paragraph (3) is the holder of a licence issued under the Ionising Radiation (Medical Exposure) Regulations 2017;
(b)in Northern Ireland, the IRME practitioner mentioned in sub-paragraph (a) or (b) of paragraph (3) is the holder of a licence issued under the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018.
(5) Condition D is that the prescription only medicine is not a product subject to special medical prescription.
(6) Condition E is that, in the case of a prescription only medicine that is not a radioactive substance, it is specified in the protocols referred to in paragraph (2).
(7) In this regulation—
“IRME practitioner” means—
in relation to a medical exposure in England and Wales and Scotland, a practitioner for the purposes of the Ionising Radiation (Medical Exposure) Regulations 2017;
in relation to a medical exposure in Northern Ireland, a practitioner for the purposes of the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018;
“medical exposure” has the same meaning—
in England and Wales and Scotland as in the Ionising Radiation (Medical Exposure) Regulations 2017;
in Northern Ireland as in the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018;
“radioactive substance” has the same meaning—
in England and Wales and Scotland as in the Ionising Radiation (Medical Exposure) Regulations 2017;
in Northern Ireland as in the Ionising Radiation (Medical Exposure) Regulations (Northern Ireland) 2018.”.]
Textual Amendments
F2Sch. 4 para. 2(2) substituted (6.2.2018) by The Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018 (S.I. 2018/121), regs. 1(2), 2(4)(b)(i)
F3Sch. 4 para. 2(3) substituted (6.2.2018) by The Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018 (S.I. 2018/121), regs. 1(2), 2(4)(b)(ii)
Commencement Information
I10Sch. 4 para. 2 in force at 6.2.2018, see reg. 1
3.—(1) The Ionising Radiations Regulations 2017(3) are amended as follows.
(2) In regulation 2(1) (interpretation)—
(a)omit the definition of “carers and comforters”;
(b)insert after the definition of “calendar year”—
““carers and comforters” means individuals knowingly and willingly incurring an exposure to ionising radiation by helping, other than as part of their occupation, in the support and comfort of individuals undergoing or having undergone a medical exposure (other than as a carer and comforter);”;
(c)in the definition of “medical exposure”, after paragraph (d), insert—
“(e)carers and comforters;”.
(3) In regulation 3 (application)—
(a)in paragraph (2), omit “33”;
(b)omit paragraph (4).
(4) Omit regulation 33 (equipment used for medical exposure).
(5) In regulation 35(6) (duties of employees)—
(a)in sub-paragraph (a), after “overexposure;” insert “or”;
(b)in sub-paragraph (b), omit “or” the second time it appears;
(c)omit sub-paragraph (c).
(6) In regulation 38(2)(d) (exemption certificates)—
(a)before “25(2)” insert “and”;
(b)omit “and 33(1)”.
Commencement Information
I11Sch. 4 para. 3 in force at 6.2.2018, see reg. 1
S.I. 2004/1769; there are amending instruments but none is relevant.
S.I. 2012/1916 as amended by S.I. 2014/490; there are other amending instruments but none is relevant.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: